Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus

Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus

Background: Type 2 diabetes mellitus (DM) is a risk factor for mycobacterial pulmonary infections (MPI), including tuberculosis (TB) and nontuberculous mycobacterial lung disease (NTM-LD). Dipeptidyl peptidase IV inhibitor (DPP4i), a common DM medication, has an immune-modulation effect that raises...

Full description

Bibliographic Details
Main Authors:	Cheng-Yi Wang, Kuang-Ming Liao, Ya-Hui Wang, Kuang-Hung Chen, Shulin Chuang, Chia-Jung Liu, Chin-Chung Shu, Hao-Chien Wang
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Journal of Infection and Public Health
Subjects:	Diabetes mellitus Dipeptidyl peptidase IV inhibitors Nontuberculous mycobacterial lung disease Mycobacterial pulmonary infection Tuberculosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S187603412300285X

Similar Items

Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al.

Mendelian susceptibility to mycobacterial infection in man
by: J-L Casanova
Published: (2001-08-01)

Anti-Mycobacterial Peptides: From Human to Phage
by: Tieshan Teng, et al.
Published: (2015-01-01)

Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review
by: Bai A, et al.
Published: (2021-12-01)

Identification and Characterization of Dipeptidyl Peptidase-IV Inhibitory Peptides from Oat Proteins
by: Wei Wang, et al.
Published: (2022-05-01)

Dipeptidyl peptidase IV (DDP IV) in NASH patients
by: Yasemin H. Balaban, et al.
Published: (2007-10-01)

Clinico-microbiological Profile of Nontuberculous Mycobacterial Keratitis
by: Richa Dhiman, et al.
Published: (2022-05-01)

Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
by: Juan Wang, et al.
Published: (2022-11-01)

The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy
by: Zhicheng Zheng, et al.
Published: (2021-05-01)

Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides
by: Alice B. Nongonierma, et al.
Published: (2013-10-01)

Molecular Characterization and Functional Analysis of the Dipeptidyl Peptidase IV from Venom of the Ectoparasitoid <i>Scleroderma guani</i>
by: Chaoyan Wu, et al.
Published: (2023-04-01)

The lung microbiota in Korean patients with non-tuberculous mycobacterial pulmonary disease
by: Sung-Yoon Kang, et al.
Published: (2021-03-01)

Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review
by: Maja Kiselinova, et al.
Published: (2023-12-01)

Mortality Rate and Cause of Death in Adults with Extrapulmonary Nontuberculous Mycobacteria Infection, Denmark
by: Andreas A. Pedersen, et al.
Published: (2024-09-01)

The roles of dipeptidyl peptidase-4 inhibitors in prognosis of COVID-19 infection in patients with type 2 diabetes mellitus
by: Mohammad Sadidi, et al.
Published: (2022-01-01)

Study of the Stability of Functionalized Gold Nanoparticles for the Colorimetric Detection of Dipeptidyl Peptidase IV
by: Hasan Aldewachi, et al.
Published: (2018-12-01)

Inhibitory effects of selected cannabinoids against dipeptidyl peptidase IV, an enzyme linked to type 2 diabetes
by: Lithalethu Mkabayi, et al.
Published: (2024-01-01)

Quercetin and Coumarin Inhibit Dipeptidyl Peptidase-IV and Exhibits Antioxidant Properties: In Silico, In Vitro, Ex Vivo
by: Anand-Krishna Singh, et al.
Published: (2020-01-01)

Clinical characteristics and imaging features of patients with nontuberculous mycobacteria in a tertiary care center
by: Talal Almutairi, et al.
Published: (2022-02-01)

Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
by: Yosuke Mai, et al.
Published: (2018-04-01)

The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review
by: L. M. Pechmann, et al.
Published: (2024-07-01)

Micro-Environmental Signature of The Interactions between Druggable Target Protein, Dipeptidyl Peptidase-IV, and Anti-Diabetic Drugs
by: Chiranjib Chakraborty, et al.
Published: (2017-01-01)

Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV
by: Keiko Yamamoto, et al.
Published: (2020-01-01)

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
by: Yosuke Mai, et al.
Published: (2019-05-01)

Anti-diabetic potential of Urena lobata leaf extract through inhibition of dipeptidyl peptidase IV activity
by: Yudi Purnomo, et al.
Published: (2015-08-01)

The Study of Associated Factors for Non-Tuberculous Mycobacterial Pulmonary Disease Compared to Pulmonary Tuberculosis: A Propensity Score Matching Analysis
by: Zhang W, et al.
Published: (2024-07-01)

Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001–2011
by: Tsai-Ling Liao, et al.
Published: (2015-08-01)

Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis
by: Sung Hyun Yoon, et al.
Published: (2024-09-01)

A successful salvage story: Uveitis with nontuberculous mycobacterial infection in a patient on secukinumab
by: Rajesh Venkitakrishnan, et al.
Published: (2022-01-01)

Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
by: Shunsuke Uno, et al.
Published: (2020-10-01)

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
by: Xuanyou Jin, et al.
Published: (2020-11-01)

Tuberculosis and Nontuberculous Mycobacterial Infections in Patients with Spondyloarthritis: A Population-Based Study
by: Jiyoul Yang, et al.
Published: (2024-03-01)

Nontuberculous Mycobacterial Infection after Fractionated CO2 Laser Resurfacing
by: Donna A. Culton, et al.
Published: (2013-03-01)

Inhibitory activity of xanthoangelol isolated from Ashitaba (Angelica keiskei Koidzumi) towards α-glucosidase and dipeptidyl peptidase-IV: in silico and in vitro studies
by: Diah Lia Aulifa, et al.
Published: (2022-05-01)

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
by: Sangmo Hong, et al.
Published: (2022-01-01)

Preparation and Purification of Dipeptidyl Peptidase-IV Inhibitory Peptides from Pearl Mussel Muscle
by: ZHANG Chuhan, CHEN Yinge, MA Ting, WENG Ling, ZHANG Lingjing, ZHANG Genfang, CAO Minjie
Published: (2024-09-01)

The Clinical Experience of Mycobacterial Culture Yield of Pleural Tissue by Pleuroscopic Pleural Biopsy among Tuberculous Pleurisy Patients
by: Chung-Shu Lee, et al.
Published: (2022-09-01)

Surgical Treatment of Nontuberculous Mycobacterial Pulmonary Disease and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis
by: Dmitry Borisivich Giller, et al.
Published: (2022-07-01)

Discovery and functional mechanism of novel dipeptidyl peptidase Ⅳ inhibitory peptides from Chinese traditional fermented fish (Chouguiyu)
by: Daqiao Yang, et al.
Published: (2022-01-01)

The Effect of Bioactive Polyphenols from <i>Anacardium occidentale</i> Linn. Leaves on α-Amylase and Dipeptidyl Peptidase IV Activities
by: Nur Imanina Abdullah Thaidi, et al.
Published: (2020-07-01)